| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94ff2d78578d95d1e8d3a2233c76188d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59 |
| filingDate |
1985-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ae2677d6a92c581fd6d92d7671654dc |
| publicationDate |
1985-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-3514584-A1 |
| titleOfInvention |
USE OF A TWO OR MULTIPHASE AGENT FOR TREATING OR PREVENTING OSTEOPOROSIS |
| abstract |
The invention relates to a two-phase composition for the treatment or prevention of osteoporosis. Bone cells are synchronised during a bone cell activation period; resorption of bone which normally follows this activation is inhibited by using polyphosphonate; bone formation can take place in the resting period during which food supplements are administered to the patient. The method shortens the natural cycle time of bone formation/resorption, which results in faster osteogenesis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0813414-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3925185-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0813414-A1 |
| priorityDate |
1984-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |